Adipokine signaling in the peritoneal dialysis patient

Contributions to Nephrology

Volumn 150, Issue , 2006, Pages 166-173

  Axelsson, Jonas ^a   Carrero, Juan Jesús ^a   Avesani, Carla Maria ^a   Heimbürger, Olof ^a   Lindholm, Bengt ^a   Stenvinkel, Peter ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; LEPTIN; RESISTIN;

ADIPOSE TISSUE; BODY MASS; HUMAN; INFLAMMATION; MACROPHAGE; METABOLISM; PERITONEAL DIALYSIS; PHYSIOLOGY; REVIEW; SIGNAL TRANSDUCTION;

ADIPONECTIN; ADIPOSE TISSUE; BODY MASS INDEX; HUMANS; INFLAMMATION; LEPTIN; MACROPHAGES; PERITONEAL DIALYSIS; RESISTIN; SIGNAL TRANSDUCTION;

EID: 33745228928     PISSN: 03025144     EISSN: None     Source Type: Book Series    
DOI: 10.1159/000093517     Document Type: Review

References (32)

1. Axelsson J, Heimbürger O, Lindholm B, Stenvinkel P: Adipose tissue and its relation to inflammation: the role of adipokines. J Ren Nutr 2005;15:131-136.
2. Nordfors L, Heimbürger O, Lönnqvist F, Lindholm B, Helmrich J, Schalling M, et al: Fat tissue accumulation during peritoneal dialysis is associated with a polymorphism in uncoupling protein 2. Kidney Int 2000;57:1713-1719.
3. Stenvinkel P: Inflammation in end-stage renal disease - a fire that burns within. Contrib Nephrol 2005;149:185-199.
4. Nawrocki A, Scherer PE: The delicate balance between fat and muscle: adipokines in metabolic disease and musculoskeletal inflammation. Curr Opin Pharm 2004;4:281-289.
5. Wellen KE, Hotamisligil GS: Inflammation, stress, and diabetes. J Clin Invest 2005;115:1111-1119.
6. Pecoits-Filho R, Heimbürger O, Bárány P, Suliman M, Fehrman-Ekholm I, Lindholm B, et al: Associations between circulating inflammatory markers and residual renal function in CRF patients. Am J Kidney Dis 2003;41:1212-1218.
7. Zhang Y, Proenca R, Maffei M, Barone M, Lori L, Friedman JM: Positional cloning of the mouse obese gene and its human homolouge. Nature 1994;372:425-432.
8. Heimbürger O, Lönnqvist F, Danielsson A, Nordenström J, Stenvinkel P: Serum immunoreactive leptin concentration and its relation to the body fat content in chronic renal failure. J Am Soc Nephrol 1997;8:1423-1430.
9. Cheung W, Yu PX, Little BM, Cone RD, Marks DL, Mak RH: Role of leptin and melanocortin signaling in uremia-associated cachexia. J Clin Invest 2005;115:1659-1665.
10. Stenvinkel P, Lindholm B, Lönnqvist F, Katzarski K, Heimbürger O: Increases in serum leptin during peritoneal dialysis are associated with inflammation and a decrease in lean body mass. J Am Soc Nephrol 2000;11:1303-1309.
11. Axelsson J, Qureshi AR, Heimbürger O, Lindholm B, Stenvinkel P, Barany P: Body fat mass and serum leptin levels influence epoetin sensitivity in patients with ESRD. Am J Kidney Dis 2005;46:628-634.
12. Ducy P, Amling M, Takeda S, Priemel M, Schilling AF, Beil FT, et al: Leptin inhibits bone formation through a hypothalamic relay: a central control of bone mass. Cell 2000;100:197-207.
13. Cao Q, Mak KM, Lieber CS: Leptin enhances alpha1(I) collagen gene expression in LX-2 human hepatic stellate cells through JAK-mediated H(2)O(2)-dependent MAPK pathways. J Cell Biochem 2005.
14. Parhami F, Tintut Y, Ballard A, Fogelman AM, Demer LL: Leptin enhances the calcification of vascular cells: artery wall as a target of leptin. Circ Res 2001;88:954-960.
15. Zoccali F, Mallamaci F, Tripepi G, Cutrupi S, Parlongo S, Malatino L, et al: Adiponectin, metabolic risk factors, and cardiovascular events among patients with end-stage renal disease. J Am Soc Nephrol 2002;13:134-141.
16. Stenvinkel P, Marchlewska A, Pecoits-Filho R, Heimbürger O, Zhang Z, Hoff C, et al: Adiponectin in renal disease: relationship to phenotype and genetic variation in the gene encoding adiponectin. Kidney Int 2004;65:274-281.
17. Huang C, Yen CJ, Chiang HW, Hung KY, Tsai TJ, Wu KD: Adiponectin in peritoneal dialysis patients: a comparison with hemodialysis patients and subjects with normal renal function. Am J Kidney Dis 2004;43:1047-1055.
18. Diez JJ, Iglesias P, Fernandez-Reyes MJ, Aguilera A, Bajo MA, Alvarez-Fidalgo P, et al: Serum concentrations of leptin, adiponectin and resistin, and their relationship with cardiovascular disease in patients with end-stage renal disease. Clin Endocrinol (Oxf) 2005;62:242-249.
19. Qi Y, Takahashi N, Hileman SM, Patel HR, Berg AH, Pajvani UB, et al: Adiponectin acts in the brain to decrease body weight. Nat Med 2004;10:524-529.
20. Shibata R, Sato K, Pimentel DR, Takemura Y, Kihara S, Ohashi K, et al: Adiponectin protects against myocardial ischemia-reperfusion injury through AMPK- and COX-2-dependent mechanisms. Nat Med 2005;11:1096-1103.
21. Holcomb IN, Kabakoff RC, Chan B, Baker TW, Gurney A, Henzel W, et al: FIZZ1, a novel cysteine-rich secreted protein associated with pulmonary inflammation, defines a new gene family. EMBO J 2000;19:4046-4055.
22. Rea R, Donnelly R: Resistin: an adipocyte-derived hormone. Has it a role in diabetes and obesity? Diabetes Obes Metab 2004;6:163-170.
23. Osawa H, Onuma H, Ochi M, Murakami A, Yamauchi J, Takasuka T, et al: Resistin SNP-420 determines its monocyte mRNA and serum levels inducing type 2 diabetes. Biochem Biophys Res Commun 2005;335:596-602.
24. Axelsson J, Marchlewska A, Qureshi AR, Heimbürger O, Barany P, Lindholm B, et al: Circulating resistin levels correlate with residual renal function and inflammation, but not with insulin resistance in patients with end-stage renal disease. Kidney Int 2006; in press.
25. Filippidis G, Liakopoulos V, Mertens PR, Kiropoulos T, Stakias N, Verikouki C, et al: Resistin serum levels are increased but not correlated with insulin resistance in chronic hemodialysis patients. Blood Purif 2005;23:421-428.
26. Axelsson J, Qureshi AR, Suliman ME, Honda H, Pecoits-Filho R, Heimbürger O, et al: Truncal fat mass as a contributor to inflammation in end-stage renal disease. Am J Clin Nutr 2004;80:1222-1229.
27. Nordfors L, Heimbürger O, Lönnqvist F, Lindholm B, Helmrich J, Schalling M, et al: Fat tissue accumulation during peritoneal dialysis is associated with a polymorphism in uncoupling protein 2. Kidney Int 2000;57:1713-1719.
28. Mohamed-Ali V, Goodrick S, Rawesh A, Katz DR, Miles JM, Yudkin JS, et al: Subcutaneous adipose tissue releases interleukin-6, but not tumour necrosis factor-α, in vivo. J Clin Endocrinol Metab 1997;82:4196-4200.
29. Kalantar-Zadeh K, Abbott KC, Salahudeen AK, Kilpatrick RD, Horwich TB: Survival advantages of obesity in dialysis patients. Am J Clin Nutr 2005;81:543-554.
30. Beddhu S, Pappas LM, Ramkumar N, Samore MH: Effects of body size and body composition on survival in hemodialysis patients. J Am Soc Nephrol 2003;14:2366-2372.
31. Snyder JJ, Foley RN, Gilbertson DT, Vonesh EF, Collins AJ: Body size and outcomes on peritoneal dialysis in the United States. Kidney Int 2003;64:1838-1844.
32. de Araújo IKM, Draibe S, Canziani M, Manfredi S, Avesani C, Sesso R, Cuppari L: Nutritional parameters and mortality in incident hemodialysis patients: effect of body mass index, muscle mass, and dietary intake. J Ren Nutr 2006; in press.